학술논문
Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG
Document Type
Article
Author
Source
In Annals of Oncology April 2006 17(4):563-570
Subject
Language
ISSN
0923-7534